ArticleMedicina (Kaunas, Lithuania)2026

Clinicopathological Predictors of Pathological Complete Response in HER2-Positive Breast Cancer Treated with Pertuzumab-Based Neoadjuvant Therapy: A Multicenter Real-World Study.

Fatih Yıldız et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.